openPR Logo
Press release

Investigation announced for Long-Term Investors in shares of Zynex, Inc. (NASDAQ: ZYXI) over potential Wrongdoing

An investigation on behalf of current long term investors in Zynex, Inc. (NASDAQ: ZYXI) shares.

An investigation on behalf of current long term investors in Zynex, Inc. (NASDAQ: ZYXI) shares.

An investigation was announced for long-term investors in shares of Zynex, Inc. (NASDAQ: ZYXI) concerning potential breaches of fiduciary duties by certain directors of Zynex, Inc.

Investors who are current long term investors in Zynex, Inc. (NASDAQ: ZYXI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in Zynex, Inc. (NASDAQ: ZYXI stocks follows a lawsuit filed against Zynex, Inc. (NASDAQ: ZYXI over alleged securities laws violations. The investigation on behalf of current long term investors in Zynex, Inc. (NASDAQ: ZYXI stocks, concerns whether certain Zynex, Inc. (NASDAQ: ZYXI officers and directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the District of Colorado the plaintiff alleges that, the Defendants failed to disclose to investors that Zynex shipped products, including electrodes, in excess of need, that, as a result of this practice, the Company inflated its revenue, that the Company's practice of filing false claims drew scrutiny from insurers, including Tricare, that, as a result, it was reasonably likely that Zynex would face adverse consequences, including removal from insurer networks and penalties from the federal government, and that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Those who purchased shares of Zynex, Inc. (NASDAQ: ZYXI) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in shares of Zynex, Inc. (NASDAQ: ZYXI) over potential Wrongdoing here

News-ID: 4041113 • Views:

More Releases from Shareholders Foundation, Inc.

Lawsuit filed for Investors who lost money with shares of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA)
Lawsuit filed for Investors who lost money with shares of Iovance Biotherapeutic …
An investor, who purchased shares of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), filed a lawsuit i over alleged violations of Federal Securities Laws by Iovance Biotherapeutics, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) have certain options and for certain investors are short and strict deadlines running. Deadline: July 14, 2025. NASDAQ: IOVA investors should contact the Shareholders Foundation at
Investors who lost money with shares of Elevance Health, Inc. (NYSE: ELV) should contact the Shareholders Foundation in connection with Lawsuit
Investors who lost money with shares of Elevance Health, Inc. (NYSE: ELV) should …
An investor in shares of Elevance Health, Inc. (NYSE: ELV) filed a lawsuit over alleged violations of Federal Securities Laws by Elevance Health, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Elevance Health, Inc. (NYSE: ELV) have certain options and for certain investors are short and strict deadlines running. Deadline: July 11, 2025. NYSE: ELV investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or
Lawsuit filed for Investors who lost money with Bitfarms Ltd. (NASDAQ: BITF) shares
Lawsuit filed for Investors who lost money with Bitfarms Ltd. (NASDAQ: BITF) sha …
An investor, who purchased shares of Bitfarms Ltd. (NASDAQ: BITF), filed a lawsuit over alleged violations of Federal Securities Laws by Bitfarms Ltd. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Bitfarms Ltd. (NASDAQ: BITF) have certain options and for certain investors are short and strict deadlines running. Deadline: July 8, 2025. NASDAQ: BITF investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
Lawsuit filed for Investors who lost money with shares of Compass Diversified (NYSE: CODI)
Lawsuit filed for Investors who lost money with shares of Compass Diversified (N …
An investor, who purchased shares of Compass Diversified (NYSE: CODI), filed a lawsuit in the U.S. District Court for the Central District of California over alleged violations of Federal Securities Laws by Compass Diversified. Investors who purchased shares of Compass Diversified (NYSE: CODI) have certain options and for certain investors are short and strict deadlines running. Deadline: July 8, 2025. NYSE: CODI investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or

All 5 Releases


More Releases for Zynex

Electrotherapy Device Market New Study Offers Insights for 2028 | NeuroMetrix, Z …
Making investment in the products or services is done in an effective way to gain huge gains through this Electrotherapy Device market survey report. It highlights on competition level in the global market for the forecast period 2022-2028. It allows retail investors in tracking the marketing strategies for the purpose of getting right investment opportunities. This market research also assesses the status of the firm. It signifies the current condition
Electrotherapy System Market Generated Opportunities and Future Scope by Major K …
CMI Research has released the latest version of its survey report on the Electrotherapy System Market, which includes 100+ market data tables, a pie chart, graphs and figures scattered over pages. The market is currently expanding its footprint. The research study includes a future trend, current growth factors, attentive opinions, facts, and industry confirmed market data, as well as a full assessment of the market. Estimates for Electrotherapy System Forecast
Muscle Stimulator Market Projected to Show Strong Growth 2027 | Omron, Zynex, Ne …
The global Muscle Stimulator market was valued at 535.88 Million USD in 2020 and will grow with a CAGR of 3.51% from 2021 to 2027. The muscle simulator market is expected to grow in the following decade, thanks to the introduction of new revolutionary technologies, increased health consciousness among the elderly, increased healthcare expenditures, and advanced therapies in sports medicine. Increased prices, particularly in emerging nations, can stifle the expansion
Muscle Stimulator Industry Size Analysis, Industry Outlook, Regional Forecast 20 …
The global Muscle Stimulator market was valued at 535.88 Million USD in 2020 and will grow with a CAGR of 3.51% from 2021 to 2027. Increased preference among physiotherapists for muscle stimulators further supports market expansion. Physiotherapists increasingly change the choice for patients in clinical and home-based therapy from manual approaches to muscular stimulators, because they use less time and are more efficient. Due to the presence of significant players, the
Global Physiotherapy Devices Market 2020 Business Strategies – Patterson Medic …
The Zion Market Research added a new report “Physiotherapy Devices Market: by Product (Equipment and Accessories), by Application (Musculoskeletal, Neurology, Cardiovascular, and Others) and by End-User (Hospitals, Physiotherapy Clinic, Rehabilitation Center, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024” in its database, which provides an expert and in-depth analysis of key business trends and future market development prospects, key drivers and restraints, profiles of major market
Feb 9, 2018: Electrotherapy Device Market Share 2018-2025 EME srl, Zynex, ERKA, …
MarketsResearch.Biz Recently added detailed market study on the "Global Electrotherapy Device Market Research Report 2018-2025" which provides an outlook of current market value of Electrotherapy Device Market as well as the expected forecast of Rate on Investment (ROI) with growing CAGR of XX% in Electrotherapy Device Market by the end of 2025. The report on the global Electrotherapy Device market uses the top-down and bottom-up approaches to define, analyze, and